<DOC>
	<DOCNO>NCT02820194</DOCNO>
	<brief_summary>The trial design perform rigorous evaluation efficacy tolerability SBRT mean randomise , control trial patient affect inoperable colorectal liver metastasis . The chosen comparator MWA . The two modality treatment ( SBRT versus MWA ) evaluate short- longer-term outcome .</brief_summary>
	<brief_title>A Trial SBRT Versus MWA Inoperable Colorectal Liver Metastases ( CLM )</brief_title>
	<detailed_description>The trial monocentric prospective , randomise control , unblinded , parallel-group superiority trial Stereotactic Body Radiation Therapy ( SBRT ) versus Microwave Ablation ( MWA ) curative treatment inoperable colorectal liver metastasis . Patients randomise equal basis either SBRT MWA . The two modality treatment ( SBRT versus MWA ) evaluate short- longer-term outcome . The key short-term outcome include assessment local response rate acute toxicity . Longer-term outcome concentrate oncological aspect disease analysis disease-free overall survival local recurrence rate 3-year follow-up .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Karnofsky index &gt; 70 % Histological proven adenocarcinoma colon rectum radiological ( CT MRI ) histological/cytological verify liver metastasis . Metastases must visible diagnostic dose plan CT scan ultrasonography . The patient suitable surgical resection due technical patientrelated condition . Resectability must judge trained hepatobiliary surgeon discuss multidisciplinary team meeting . Presence 13 lesion . Diameter ≤ 40 mm . All tumor feasible treatment two modality , SBRT MWA Adequate liver function : bilirubin &lt; 1.5 mg/dl , alb &gt; 3.5g/dl , normal PT/PTT except patient us anticoagulant , liver enzymes &lt; 3 time upper limit normal . No ascites . Renal function must adequate infusion iv . contrast CTscan . Adequate bone marrow function : Hbg³8 g/dl , platelets³100.000 leucocytes ³2.000/ml . Informed consent . Extrahepatic disease stable response CT No previous abdominal radiation therapy ( RT ) Uncontrolled primary tumor extrahepatic disease Previous abdominal radiation therapy ( RT ) local conservative treatment lesion target . Pregnant breastfeeding patient . Prior malignancy within last five year ( except adequately treat basal cell carcinoma skin situ carcinoma skin situ carcinoma cervix , surgically cure , localized prostate cancer without evidence biochemical progression ) . Previous inclusion study . Underlying liver cirrhosis ( ChildPugh grade B C ) . Ascites and/or relevant intrahepatic biliary tract dilatation . Mental condition render patient incapable understand nature , scope , consequence study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>